Table : Odds ratios and hazard ratios with confidence intervals estimated for risk factors for neuropsychiatric damage Author name Date Damage outcome Disease Activity Ethnicity anticardiolipids Organ damage Steroid Anti-malarials Diabetes Age Hypertension Mikdashi (184) 2004 Neuropsychiatric 2.7 (1.0-6.7) 3.0 (1.0-19.5) 4.8 (1.0-23.0) damage (OR) Mok (185) 2006 Neuropsychiatric 1.28 (1.29-1.31) 1.16 (1.10-1.23) damage (HR) Gonzalez (186) 2009 Neuropsychiatric 1.16 (1.12–1.21) 1.87 (1.22–2.87) 0.56 (0.35–0.92) 0.58 (0.36–0.93) 3.47 (1.44–8.38) damage (HR) Mikdashi (187) 2005 Seizures(OR) 2.29 (1.01-1.12) 2.23 (1.01–4.67) Andrade (188) 2008 Seizures (HR) 1.10 (1.04- 1.15) 2.7 (1.3–5.7) 0.35 (0.15- 0.80) 1.04 (1.00-1.08) 2008 Seizure (HR) 1.0 (0.9–1.0) (189) Mikdashi (190) 2007 Stroke (HR) 1.31 (0.40-4.31) 1.11 (0.43–2.84) 1.00 (0.98–1.03) 2.31 (1.15–4.65) HR Hazard ratios, OR Odds ratios; aCL anticardiolipin antibodies
Table : Odds ratios and hazard ratios with confidence intervals estimated for risk factors for neuropsychiatric damage Author name Date Damage outcome Disease Activity Ethnicity anticardiolipids Organ damage Steroid Anti-malarials Diabetes Age Hypertension Mikdashi (184) 2004 Neuropsychiatric damage (OR) 2.7 (1.0-6.7) 3.0 (1.0-19.5) 4.8 (1.0-23.0) Mok (185) 2006 Neuropsychiatric damage (HR) 1.28 (1.29-1.31) 1.16 (1.10-1.23) Gonzalez (186) 2009 Neuropsychiatric damage (HR) 1.16 (1.12–1.21) 1.87 (1.22–2.87) 0.56 (0.35–0.92) 0.58 (0.36–0.93) 3.47 (1.44–8.38) Mikdashi (187) 2005 Seizures(OR) 2.29 (1.01-1.12) 2.23 (1.01–4.67) Andrade (188) 2008 Seizures (HR) 1.10 (1.04- 1.15) 2.7 (1.3–5.7) 0.35 (0.15- 0.80) 1.04 (1.00-1.08) (189) 2008 Seizure (HR) 1.0 (0.9–1.0) Mikdashi (190) 2007 Stroke (HR) 1.31 (0.40-4.31) 1.11 (0.43–2.84) 1.00 (0.98–1.03) 2.31 (1.15–4.65) HR Hazard ratios, OR Odds ratios; aCL anticardiolipin antibodies
Final%20Thesis%20with%20Corrections.docx